An interventional study of Beta-alanine and Control product consumption in Product Safety, sponsored by Universidad Católica San Antonio de Murcia. Completed at 1 site in Spain. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-26.
Sponsored by Universidad Católica San Antonio de Murcia · Not applicable, Interventional, and Other
Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.
After recruitment, subjects will be randomized and assigned to one of the two arms of the study: beta-alanine group or control group (placebo).
Subjects must be active people, and will take a dose of 15 g per day of the product for 4 weeks.
Universidad Católica San Antonio de Murcia is the lead sponsor of 138 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.
Dietary Supplement: Beta-alanine
The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.
Other: Control product consumption
The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.
Product with identical characteristics to the experimental product. The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.
Liver safety variables
It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver. Enzyme GPT, GOT, Gamma GT, LDH, alkaline phosphatase and bilirubin (UI/L)
Time frame: Change in hepatic safety after 8 weeks of consumption
Paresthesia test
Visual analogue scale (1-10)
Time frame: Change after 8 weeks of consumption
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Beta-Alanine
Universidad Católica San Antonio de Murcia →